Rallis India delivered a resilient Q1 FY27, hitting record EBITDA despite a tough environment with delayed monsoons and crop shifts.

Revenue rose 7% to ₹1,022 Cr, fueled by strong domestic formulation sales.

EBITDA jumped 23% to ₹184 Cr, with Profit After Tax (PAT) up 31% to ₹125 Cr.

Key highlights include a robust 19% revenue growth in B2C Crop Protection and a 10% increase in Soil & Plant Health solutions.

While B2B exports and Custom Synthesis Manufacturing (CSM) faced a 16% decline, the Seeds business grew 6% despite delayed sowings.

Strategically, Rallis is expanding its portfolio in custom synthesis and Soil & Plant Health, leveraging digital tools for efficiency.

The company launched 9 new products this quarter, spanning herbicides, insecticides, specialty SPH, and new cotton hybrids.

Management credits aggressive pre-placement and liquidation efforts for navigating the challenging market and driving growth.